Search research articles
Contact Us
Filters
Showing results (371-380 of 390) with videos related to
Page
of 39
Sort By:
Annals of Hematology
|
May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
Wei Wang, Wei Zhang, Li-Ping Su, et al.
Rheumatology (Oxford, England)
|
December 23, 2023
Transcriptomic features of systemic lupus erythematosus patients in flare and changes during acute in-hospital treatment
Zhongyi Liu, Li Shao, Fei Hou, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology
|
October 21, 2021
[Preliminary report on partial pressure changes of oxygen and carbon dioxide in umbilical artery and vein before and after the first breath in Chinese neonates II-The personalized analysis of partial pressure of oxygen and carbon dioxide difference between umbilical artery and vein at same time in same newborn]
Fang Liu, Xing-Guo Sun, Qi-Wei Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
Seok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Blood Advances
|
February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults
Yan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 390) with videos related to
Sort By:
Page
of 39
Annals of Hematology
|
May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
Wei Wang, Wei Zhang, Li-Ping Su, et al.
Rheumatology (Oxford, England)
|
December 23, 2023
Transcriptomic features of systemic lupus erythematosus patients in flare and changes during acute in-hospital treatment
Zhongyi Liu, Li Shao, Fei Hou, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology
|
October 21, 2021
[Preliminary report on partial pressure changes of oxygen and carbon dioxide in umbilical artery and vein before and after the first breath in Chinese neonates II-The personalized analysis of partial pressure of oxygen and carbon dioxide difference between umbilical artery and vein at same time in same newborn]
Fang Liu, Xing-Guo Sun, Qi-Wei Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
Seok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Blood Advances
|
February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults
Yan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Page
of 39